NCT04867473

Brief Summary

Primary Aims: Modify an existing teleyoga intervention to use with Lyme disease (LD) patients and address the technical challenges of at-home teleyoga

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 30, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2022

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2022

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

March 8, 2024

Completed
Last Updated

March 8, 2024

Status Verified

August 1, 2023

Enrollment Period

1.1 years

First QC Date

April 16, 2021

Results QC Date

August 10, 2023

Last Update Submit

August 10, 2023

Conditions

Keywords

yogatelehealthchronic pain

Outcome Measures

Primary Outcomes (1)

  • Change of Pain Score From Baseline

    Scores on the Pain, Enjoyment, General Activity (PEG) Scale; with values from 0 to 10 and higher scores indicating worse outcomes

    Measured at baseline and again at the end of 12 weeks of treatment

Secondary Outcomes (1)

  • Adherence to the Treatment Protocol

    at study completion, an average of 7 months

Study Arms (1)

Teleyoga

EXPERIMENTAL

Lyme disease participants will attend home-based yoga sessions using HIPAA-compliant telehealth software and devices and complete pain inventory questionnaires pre and post-treatment

Behavioral: Teleyoga

Interventions

TeleyogaBEHAVIORAL

12 weekly 75 minute therapist-led teleyoga sessions

Teleyoga

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of probable Lyme disease
  • Has not begun new pain medications or other treatments in the last month
  • English literacy
  • Wireless internet connection at home

You may not qualify if:

  • Participation in another concurrent clinical trial
  • Back surgery within the last 12 months
  • Unstable, coexisting mental illness or psychiatric condition
  • Active, current suicidal intent or plan
  • Attended or practiced yoga ≥ 1 x in the past 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Palo Alto, California, 94305, United States

Location

MeSH Terms

Conditions

Lyme DiseaseChronic Pain

Condition Hierarchy (Ancestors)

Gram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsBorrelia InfectionsSpirochaetales InfectionsTick-Borne DiseasesVector Borne DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Peter Bayley, PhD
Organization
Stanford University

Study Officials

  • Peter J Bayley, Ph.D.

    VA Palo Alto Health Care System and Stanford University

    STUDY DIRECTOR
  • Jerome A Yesavage, M.D.

    Stanford University and VA Palo Alto Health Care System

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Participants will attend teleyoga sessions once per week, with assessments at beginning and end of treatment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

April 16, 2021

First Posted

April 30, 2021

Study Start

October 1, 2021

Primary Completion

November 10, 2022

Study Completion

December 4, 2022

Last Updated

March 8, 2024

Results First Posted

March 8, 2024

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations